Related Experiment Video
Updated: Jun 12, 2026
09:29
An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing
Published on: May 13, 2020
Respiratory effects from industrial talc exposure among former mining workers
Rosinelle Castelo Branco Ramos Loyola1, Ana Paula Scalia Carneiro, Andréa Maria Silveira
1Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Revista De Saude Publica
|May 26, 2010
Summary
Occupational talc exposure, particularly when contaminated with asbestos, can lead to significant late respiratory effects. This study highlights the increased risk of pneumoconiosis and pleural abnormalities in former talc miners.
Area of Science:
- Occupational Health
- Pulmonary Medicine
- Environmental Health
Background:
- Talc mining can expose workers to asbestos, a known carcinogen.
- Asbestos exposure is linked to serious respiratory diseases, often with a long latency period.
Purpose of the Study:
- To investigate the long-term respiratory health consequences in former talc miners exposed to asbestos-contaminated talc.
- To assess the relationship between cumulative exposure and the development of asbestos-related lung conditions.
Main Methods:
- A case series study involving 29 former talc miners with documented asbestos exposure.
- Clinical evaluation, occupational history, spirometry, and chest radiography were performed.
- A cumulative talc exposure index was calculated and analyzed using logistic regression.
Main Results:
- Radiological abnormalities suggestive of pneumoconiosis or pleural disease were observed in several workers.
- A cumulative exposure index was significantly associated with an increased risk of radiological abnormalities (OR 1.059).
- The latency period for pleural plaque diagnosis was significantly longer in affected workers (27.0 years vs. 14.3 years).
Conclusions:
- Findings underscore the critical need for ongoing clinical surveillance of workers exposed to asbestos-contaminated talc.
- Late respiratory effects, including pneumoconiosis and pleural abnormalities, necessitate vigilant monitoring and preventative measures.
Related Concept Videos
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
02:59Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations: